Water-filtered Infrared-A Radiation in Patients With Hand Osteoarthritis
NCT ID: NCT06329219
Last Updated: 2024-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
70 participants
INTERVENTIONAL
2024-03-26
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Does water-filtered Infrared-A radiation reduce pain and improve the function of finger joints over time?
* Are patients satisfied with the treatment results when compared to those who were on a wait-list?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Heated Mittens for Patients With Hand Osteoarthritis
NCT04576403
Pulsed Radiofrequency Therapy for Hand OsteoArthritis Pain
NCT05217979
Evaluation of the Effects of High Intensity Laser Therapy and Exercise in Hand Thumb Osteoarthritis
NCT07112742
Low Level Laser Therapy and Interferential Current in Osteoarthritis
NCT02898025
Strategies for Patients With Osteoarthritis, by Using Assistive Technology and Exercises.
NCT03173989
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Radiation
Participants in the intervention group each receive a hyperthermia device for water-filtered Infrared-A radiation.
water-filtered Infrared-A radiation
The water-filtered Infrared-A radiation device is designed for self-administered home treatments. The regimen prescribes 30-minute sessions, five times weekly, spanning 12 weeks.
Waiting list
Participants in the control group initially receive no therapeutic intervention, but can receive it after the study's last visit for 3 months.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
water-filtered Infrared-A radiation
The water-filtered Infrared-A radiation device is designed for self-administered home treatments. The regimen prescribes 30-minute sessions, five times weekly, spanning 12 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Local pain for more than 50% of the day in the past 3 months.
* Subjective pain intensity of local pain in the last 24 hours on a VAS scale of 0 to 10 being \>4.
* No planned local treatment in the next 6 months.
* No planned intra-articular injections within the next 6 months.
* The patient must be able to understand the study explanations and appropriately follow the instructions of the investigating physician.
Exclusion Criteria
* Poor general health.
* Febrile diseases.
* Fibromyalgia syndrome.
* Psychotic disorders.
* Severe comorbidities.
* Acute unclear skin diseases.
* Heat urticaria.
* Painful diseases/diagnoses of the shoulder and/or arm.
* Lymphatic vessel diseases (lymphedema, lymphangitis).
* Porphyria.
* Pain-associated diseases/diagnoses of the shoulder and/or arm.
* Intra-articular injections or arthroscopies within the last 3 months.
* Previous or planned surgical procedure on the affected joints in the last 8 weeks or in the upcoming 6 months.
* Intake or application of photosensitizing drugs or extracts (e.g., porphyrins, tetracyclines, sulfonamides, psoralenes, St. John's wort).
* Systemic medication with glucocorticoids or immunosuppressants.
* Pain medication with opioid analgesics.
* Known pregnancy.
* Concurrent participation in another clinical trial.
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andreas Michalsen
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas Michalsen
Role: PRINCIPAL_INVESTIGATOR
Charite University, Berlin, Germany
Rainer Stange
Role: PRINCIPAL_INVESTIGATOR
Charite University, Berlin, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charité - Universitätsmedizin Berlin at the Department of Internal and Integrative Medicine, Immanuel Krankenhaus Berlin
Wannsee, State of Berlin, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
wIRA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.